217 related articles for article (PubMed ID: 6813489)
1. Mechanisms of action of auranofin: effects on humoral immune response.
Walz DT; Dimartino MJ; Griswold DE
J Rheumatol Suppl; 1982; 8():32-6. PubMed ID: 6813489
[TBL] [Abstract][Full Text] [Related]
2. Immunopharmacology of auranofin and gold sodium thiomalate: effects on humoral immunity.
Walz DT; DiMartino MJ; Griswold DE
J Rheumatol Suppl; 1979; 5():74-81. PubMed ID: 114651
[TBL] [Abstract][Full Text] [Related]
3. Distribution of gold in rat blood after intravenous administration of auranofin, gold sodium thiomalate and aurothioglucose to rats.
Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
J Rheumatol; 1983 Feb; 10(1):117-20. PubMed ID: 6405031
[TBL] [Abstract][Full Text] [Related]
4. Ambivalent properties of gold drugs in adjuvant induced polyarthritis in rats.
Garrett IR; Whitehouse MW; Vernon-Roberts B; Brooks PM
J Rheumatol; 1985 Dec; 12(6):1079-82. PubMed ID: 3937896
[TBL] [Abstract][Full Text] [Related]
5. Biologic actions and pharmacokinetic studies of auranofin.
Walz DT; DiMartino MJ; Griswold DE; Intoccia AP; Flanagan TL
Am J Med; 1983 Dec; 75(6A):90-108. PubMed ID: 6318557
[TBL] [Abstract][Full Text] [Related]
6. The effects of auranofin and gold sodium aurothiomalate on the chemiluminescent response of stimulated synovial tissue cells from patients with rheumatoid arthritis.
Harth M; McCain GA; Orange JF
J Rheumatol; 1985 Oct; 12(5):881-4. PubMed ID: 3936929
[TBL] [Abstract][Full Text] [Related]
7. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P
Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604
[No Abstract] [Full Text] [Related]
8. Suppressed IL-2 production and response in AA rats: role of suppressor cells and the effect of auranofin treatment.
Lee JC; Rebar L; Demuth S; Hanna N
J Rheumatol; 1985 Oct; 12(5):885-91. PubMed ID: 2935633
[TBL] [Abstract][Full Text] [Related]
9. Effects of chrysotherapy on cell mediated immune response.
Lorber A; Jackson WH; Simon TM
J Rheumatol Suppl; 1982; 8():37-45. PubMed ID: 6813490
[TBL] [Abstract][Full Text] [Related]
10. Effects of gold compounds on leukotriene B4, leukotriene C4 and prostaglandin E2 production by polymorphonuclear leukocytes.
Parente JE; Wong K; Davis P; Burka JF; Percy JS
J Rheumatol; 1986 Feb; 13(1):47-51. PubMed ID: 3009806
[TBL] [Abstract][Full Text] [Related]
11. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis.
Davis P; Menard H; Thompson J; Harth M; Beaudet F
J Rheumatol; 1985 Feb; 12(1):60-7. PubMed ID: 3920393
[TBL] [Abstract][Full Text] [Related]
12. The effect of a new antirheumatic drug, triethylphosphine gold (auranofin), on in vitro lymphocyte and monocyte cytotoxicity.
Russell AS; Davis P; Miller C
J Rheumatol; 1982; 9(1):30-5. PubMed ID: 6806471
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis.
Edelman J; Davis P; Owen ET
J Rheumatol; 1983 Feb; 10(1):121-3. PubMed ID: 6405032
[TBL] [Abstract][Full Text] [Related]
14. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].
Batlle Gualda E
Med Clin (Barc); 1985 May; 84(20):834-9. PubMed ID: 3928990
[No Abstract] [Full Text] [Related]
15. Correlation of in vitro and in vivo effects of gold compounds on leukocyte function: possible mechanisms of action.
Wolach B; DeBoard JE; Coates TD; Baehner RL; Boxer LA
J Lab Clin Med; 1982 Jul; 100(1):37-44. PubMed ID: 6283001
[TBL] [Abstract][Full Text] [Related]
16. Synergistic inhibition of T cell proliferation by gold sodium thiomalate and auranofin.
Hashimoto K; Whitehurst CE; Lipsky PE
J Rheumatol; 1994 Jun; 21(6):1020-6. PubMed ID: 7932408
[TBL] [Abstract][Full Text] [Related]
17. Gold therapy in rheumatoid arthritis. Interim report of the Canadian multicenter prospective trial comparing sodium aurothiomalate and auranofin.
Menard HA; Beaudet F; Davis P; Harth M; Percy JS; Russell AS; Thompson JM
J Rheumatol Suppl; 1982; 8():179-83. PubMed ID: 6813482
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of gold following administration of auranofin (SK+FD-39162) and myochrysine to rats.
Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
J Rheumatol; 1980; 7(6):820-4. PubMed ID: 6782245
[TBL] [Abstract][Full Text] [Related]
19. The pharmacological profile of auranofin, an orally active gold compound.
Walz DT; DiMartino MJ; Griswold DE
Scand J Rheumatol Suppl; 1983; 51():16-25. PubMed ID: 6426049
[TBL] [Abstract][Full Text] [Related]
20. Comparative pharmacology and biological effects of different gold compounds.
Walz DT; DiMartino MJ; Griswold DE
J Rheumatol Suppl; 1982; 8():54-60. PubMed ID: 6813492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
